Pharma Stocks
-
Is Leqembi success strong enough to unlock new upside?
Eisai’s Alzheimer’s breakthrough Leqembi offers U.S. investors exposure to a massive unmet need in neurology. With Biogen partnership driving global…
Read More » -
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
Special continuing M&A Segment with Senior M&A Partner at Sullivan & Cromwell LLP, Frank Aquila NEW YORK CITY, NY /…
Read More » -
UroGen Pharma (URGN) Is Up 14.6% After Phase 3 ENVISION Data And LG-UTUC Outreach Push
In late March and early April 2026, UroGen Pharma announced publication of pivotal Phase 3 ENVISION data for bladder cancer…
Read More » -
Merck’s Eye Drug Trial Adds New Dimension To Growth And Valuation Narrative
Merck (NYSE:MRK) has started a pivotal Phase 2b/3 trial for MK-8748, also known as Tiespectus, in neovascular age related macular…
Read More » -
Does New Epidiolex Behavioral Data at AAN 2026 Reframe Jazz Pharmaceuticals’ (JAZZ) Neuroscience Strategy?
Jazz Pharmaceuticals recently announced it will present six abstracts, including one oral presentation, at the 2026 American Academy of Neurology…
Read More » -
Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
A pharma analyst told businessline that Sun Pharma had a good record of buying companies and integrating it – be…
Read More » -
A Look At Chugai Pharmaceutical (TSE:4519) Valuation After Recent Share Price Softness
Why Chugai Pharmaceutical Stock Is On Investors’ Radar Chugai Pharmaceutical (TSE:4519) has attracted attention after recent share price moves, with…
Read More » -
Could Indivior (INDV) Turn Correctional Staffing Efficiencies Into a Durable Competitive Edge?
Indivior Pharmaceuticals recently reported that a new cost impact model, published in The Journal of Current Medical Research and Opinion,…
Read More » -
What investors should know before buying now
You’re eyeing Astellas Pharma Inc for your portfolio—here’s the clear picture on its oncology focus, global reach, and what drives…
Read More » -
What you should know before investing now
Curious if Huadong Medicine Co Ltd offers real value in China’s pharma boom? This deep dive breaks down its business,…
Read More »